These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16309402)

  • 1. Aprotinin decreases ischemic damage during coronary revascularization.
    Lazar HL; Bao Y; Tanzillo L; O'Gara P; Reardon D; Price D; Crowley R; Cabral HJ
    J Card Surg; 2005; 20(6):519-23. PubMed ID: 16309402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest.
    Khan TA; Bianchi C; Voisine P; Feng J; Baker J; Hart M; Takahashi M; Stahl G; Sellke FW
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):602-8. PubMed ID: 15457162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nesiritide enhances myocardial protection during the revascularization of acutely ischemic myocardium.
    Lazar HL; Bao Y; Siwik D; Frame J; Mateo CS; Colucci WS
    J Card Surg; 2009; 24(5):600-5. PubMed ID: 19486217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment with statins enhances myocardial protection during coronary revascularization.
    Lazar HL; Bao Y; Zhang Y; Bernard SA
    J Thorac Cardiovasc Surg; 2003 May; 125(5):1037-42. PubMed ID: 12771876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does off-pump revascularization reduce coronary endothelial dysfunction?
    Lazar HL; Bao Y; Rivers S
    J Card Surg; 2004; 19(5):440-3. PubMed ID: 15383057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant aprotinin on postoperative blood loss and coronary vascular function in a canine model of cardiopulmonary bypass.
    Veres G; Radovits T; Schultz H; Lin LN; Hütter J; Weigang E; Szabolcs Z; Szabó G
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):340-5. PubMed ID: 17500000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of angiotensin-converting enzyme inhibitors during acute revascularization.
    Lazar HL; Volpe C; Bao Y; Rivers S; Vita JA; Keaney JF
    Ann Thorac Surg; 1998 Aug; 66(2):487-92. PubMed ID: 9725390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of purified poloxamer 407 gel on vascular occlusion and the coronary endothelium.
    Boodhwani M; Feng J; Mieno S; Ramlawi B; Sodha N; Clements R; Sellke FW
    Eur J Cardiothorac Surg; 2006 May; 29(5):736-41. PubMed ID: 16626965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprotinin preserves cellular junctions and reduces myocardial edema after regional ischemia and cardioplegic arrest.
    Khan TA; Bianchi C; Araujo E; Voisine P; Xu SH; Feng J; Li J; Sellke FW
    Circulation; 2005 Aug; 112(9 Suppl):I196-201. PubMed ID: 16159815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel synthetic serine protease inhibitor CU-2010 dose-dependently reduces postoperative blood loss and improves postischemic recovery after cardiac surgery in a canine model.
    Szabó G; Veres G; Radovits T; Haider H; Krieger N; Bährle S; Niklisch S; Miesel-Gröschel C; van de Locht A; Karck M
    J Thorac Cardiovasc Surg; 2010 Mar; 139(3):732-40. PubMed ID: 20176215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of novel synthetic serine protease inhibitors on postoperative blood loss, coagulation parameters, and vascular relaxation after cardiac surgery.
    Szabó G; Veres G; Radovits T; Haider H; Krieger N; Bährle S; Miesel-Gröschel C; Niklisch S; Karck M; van de Locht A
    J Thorac Cardiovasc Surg; 2010 Jan; 139(1):181-8; discussion 188. PubMed ID: 20106364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aprotinin decreases reperfusion injury and allograft dysfunction in clinical lung transplantation.
    Bittner HB; Richter M; Kuntze T; Rahmel A; Dahlberg P; Hertz M; Mohr FW
    Eur J Cardiothorac Surg; 2006 Feb; 29(2):210-5. PubMed ID: 16386921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
    Hale SL; Kloner RA
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tetrahydrobiopterin on selective endothelial dysfunction of epicardial porcine coronary arteries induced by cardiopulmonary bypass.
    Stevens LM; Fortier S; Aubin MC; El-Hamamsy I; Maltais S; Carrier M; Perrault LP
    Eur J Cardiothorac Surg; 2006 Sep; 30(3):464-71. PubMed ID: 16884906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Na(+)/H(+)-exchange inhibition and aprotinin administration: promising tools for myocardial protection during minimally invasive CABG.
    Hendrikx M; Rega F; Jamaer L; Valkenborgh T; Gutermann H; Mees U
    Eur J Cardiothorac Surg; 2001 May; 19(5):633-9. PubMed ID: 11343944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprotinin improves cerebral protection: evidence from a survival porcine model.
    Anttila V; Hagino I; Iwata Y; Mettler BA; Lidov HG; Zurakowski D; Jonas RA
    J Thorac Cardiovasc Surg; 2006 Oct; 132(4):948-53. PubMed ID: 17000309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does aprotinin reduce lung reperfusion damage after cardiopulmonary bypass?
    Rahman A; Ustünda B; Burma O; Ozercan IH; Cekirdekçi A; Bayar MK
    Eur J Cardiothorac Surg; 2000 Nov; 18(5):583-8. PubMed ID: 11053821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aprotinin is safe in pediatric patients undergoing cardiac surgery.
    Backer CL; Kelle AM; Stewart RD; Suresh SC; Ali FN; Cohn RA; Seshadri R; Mavroudis C
    J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1421-6; discussion 1426-8. PubMed ID: 18023656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporary coronary artery occlusion during off-pump coronary artery bypass grafting with the new poloxamer P407 does not cause endothelial dysfunction in epicardial coronary arteries.
    Bouchot O; Aubin MC; Carrier M; Cohn WE; Perrault LP
    J Thorac Cardiovasc Surg; 2006 Nov; 132(5):1144-9. PubMed ID: 17059936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.